The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis
Open accessAbstract
Background: The CANTOS trial (Canakinumab Antiinflammatory Thrombosis Outcome Study) showed that antagonism of interleukin (IL)–1β reduces coronary heart disease in patients with a previous myocardial infarction and evidence of systemic inflammation, indicating that pathways required for IL-1β secretion increase cardiovascular risk. IL-1β and IL-18 are produced via the NLRP3 inflammasome in myeloid cells in response to cholesterol accumulation, but mechanisms linking NLRP3 inflammasome activation to atherogenesis are unclear. The cholesterol transporters ATP binding cassette A1 and G1 (ABCA1/G1) mediate cholesterol efflux to high-density lipoprotein, and Abca1/g1 deficiency in myeloid cells leads to cholesterol accumulation. Methods: To interrogate mechanisms connecting inflammasome activation with atherogenesis, we used mice with myeloid Abca1/g1 deficiency and concomitant deficiency of the inflammasome components Nlrp3 or Caspase-1/11 . Bone marrow from these mice was transplanted into Ldlr −/− recipients, which were fed a Western-type diet. Results: Myeloid Abca1/g1 deficiency increased plasma IL-18 levels in Ldlr −/− mice and induced IL-1β and IL-18 secretion in splenocytes, which was reversed by Nlrp3 or Caspase-1/11 deficiency, indicating activation of the NLRP3 inflammasome. Nlrp3 or Caspase-1/11 deficiency decreased atherosclerotic lesion size in myeloid Abca1/g1 -deficient Ldlr −/− mice. Myeloid Abca1/g1 deficiency enhanced caspase-1 cleavage not only in splenic monocytes and macrophages, but also in neutrophils, and dramatically enhanced neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques, with reversal by Nlrp3 or Caspase-1/11 deficiency, suggesting that inflammasome activation promotes neutrophil recruitment and neutrophil extracellular trap formation in atherosclerotic plaques. These effects appeared to be indirectly mediated by systemic inflammation leading to activation and accumulation of neutrophils in plaques. Myeloid Abca1/g1 deficiency also activated the noncanonical inflammasome, causing increased susceptibility to lipopolysaccharide-induced mortality. Patients with Tangier disease, who carry loss-of-function mutations in ABCA1 and have increased myeloid cholesterol content, showed a marked increase in plasma IL-1β and IL-18 levels. Conclusions: Cholesterol accumulation in myeloid cells activates the NLRP3 inflammasome, which enhances neutrophil accumulation and neutrophil extracellular trap formation in atherosclerotic plaques. Patients with Tangier disease, who have increased myeloid cholesterol content, showed markers of inflammasome activation, suggesting human relevance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“induction of cholesterol efflux from myeloid cells inhibits NLRP3 inflammasome activation73.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [73]
In the citing paper
“In myeloid cells in which cholesterol efflux pathways have been genetically suppressed, accumulation of unesterified cholesterol in the cellular membranes without cholesterol crystal formation or lysosomal damage contributes to both priming and activation of the NLRP3 inflammasome73.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Self-citationMechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,579
Non-canonical inflammasome activation targets caspase-11
Kayagaki, N., Warming, S., Lamkanfi, M., Walle, L. V., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., et al. (2011) · Nature · doi:10.1038/nature10558 · Cited by 2,530
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Henao-Mejia, J., Elinav, E., Jin, C., Hao, L., Mehal, W. Z., Strowig, T., Thaiss, C. A., Kau, A. L., Eisenbarth, S. C., Jurczak, M. J., et al. (2012) · Nature · doi:10.1038/nature10809 · Cited by 2,435
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 331
Han, C. Y., Kang, I., Omer, M., Wang, S., Wietecha, T., Wight, T. N., & Chait, A. (2020) · JCI Insight · doi:10.1172/jci.insight.142635 · Cited by 14
El‐Darzi, N., Mast, N., Buchner, D. A., Saadane, A., Dailey, B., Trichonas, G., & Pikuleva, I. A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902254 · Cited by 16
The various roles of TREM2 in cardiovascular disease
Wang, S., Cao, C., & Peng, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1462508 · Cited by 16
NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity
Chen, C., Zhang, S., Sheng, M., & Shao, W. (2025) · Mediators of Inflammation · doi:10.1155/mi/4330574 · Cited by 16
Buso, G., Faggin, E., Rosenblatt‐Velin, N., Pellegrin, M., Galliazzo, S., Calanca, L., Rattazzi, M., & Mazzolai, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021169 · Cited by 13
Graham, A. (2023) · Biology · doi:10.3390/biology12091232 · Cited by 14
Wang, J., Xiao, Q., Cai, Y., Wang, M., Chen, C., Wang, L., Ma, R., Cao, Y., Wang, Y., Ding, H., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.08.005 · Cited by 16
Wang, Y., Shang, X., Zhang, Y., Zhang, Y., Shen, W., Wu, Q. V., & Du, W. (2025) · BMC Public Health · doi:10.1186/s12889-025-21392-5 · Cited by 13
Shen, L., Jiang, C., Song, J., Bi, Y., Chen, W., Lu, C., Chen, M., Lv, L., Yu, R., Zou, J., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114000 · Cited by 14
Jiang, C., Yao, D., Shen, Q., Tian, R., Fan, L., Qiang, Z., Qian, X., Liu, Z., Huang, Y., & Dong, N. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf159 · Cited by 14
Crosstalk Between Cholesterol, ABC Transporters, and PIP2 in Inflammation and Atherosclerosis
Gulshan, K. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-21547-6_13 · Cited by 12
Dergunov, A. D., Nosova, E. V., Rozhkova, A. V., Vinogradina, M. A., Baserova, V. B., Popov, M. A., Limborska, S. A., & Dergunova, L. V. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080431 · Cited by 12
Nappi, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010047 · Cited by 12
Yin, Q.-X., Chang, H., Shen, Q., & Xing, D. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16531 · Cited by 12
LncRNA MDRL Mitigates Atherosclerosis through miR-361/SQSTM1/NLRP3 Signaling
You, L., Zheng, Y., Yang, J., Hou, Q., Wang, L., Zhang, Y., Zhao, C., & Xie, R. (2022) · Mediators of Inflammation · doi:10.1155/2022/5463505 · Cited by 13
Hyperlipidemia and Allograft Rejection
Bagley, J., Williams, L., Hyde, M., Birriel, C. R., & Iacomini, J. (2019) · Current Transplantation Reports · doi:10.1007/s40472-019-0232-2 · Cited by 13
Khan, F. A., Radovanović, A., Gojobori, T., & Kaur, M. (2021) · Database · doi:10.1093/database/baab022 · Cited by 11
Liu, Y., Ma, S., Li, F., Ding, H., Zhang, Q., Yu, F., Zhang, H., Hao, Y., Liu, B., & Jiang, Y. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03444-5 · Cited by 13
Self-citationSilvain, J., Materne, C., Zeitouni, M., Procopi, N., Guedeney, P., Brugier, D., Galier, S., Lhomme, M., Ponnaiah, M., Guillas, I., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae356 · Cited by 11
Zhang, H.-M., de Urturi, D. S., Fernández-Tussy, P., Huang, Y., Jovin, D. G., Zhang, X.-B., Huang, S.-S., Lek, M., Catarino, J. D. S., Sternak, M., et al. (2025) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2417512122 · Cited by 12
Self-citationLiu, Y., Wang, K., Yang, S., Xue, G., & Lu, L. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3296 · Cited by 11
Da, H., Yang, R., Liang, J., Wang, J., Yang, W., Dunk, M. M., Qi, X., & Xu, W. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.02.022 · Cited by 11
SENP3 attenuates foam cell formation by deSUMOylating NLRP3 in macrophages stimulated with ox-LDL
Chen, J., Sun, X., Liu, Y., Zhang, Y., Zhao, M., & Shao, L. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111092 · Cited by 11
Endo, Y., Sasaki, K., & Ikewaki, K. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22020 · Cited by 11
A new pathway of macrophage cholesterol efflux
Westerterp, M., & Tall, A. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007836117 · Cited by 10
Self-citationSong, X., Yan, G., Wang, H., & Lou, D. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10195 · Cited by 10
Karpouzas, G. A., Papotti, B., Ormseth, S. R., Palumbo, M., Hernández, E., Adorni, M. P., Zimetti, F., Budoff, M. J., & Ronda, N. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103029 · Cited by 10
Role of Neutrophil Extracellular Traps in Hypertension and Their Impact on Target Organs
Yu, F., Chen, J., Zhang, X., Ma, Z., Wang, J., & Wu, Q. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14942 · Cited by 9
A new perspective on the current and future development potential of ABCG1
Zeng, G.-G., Lei, Q., Jiang, W., Zhang, X., Nie, L.-L., Gong, X., & Zheng, K. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102161 · Cited by 8
Macrophage pyroptosis induced by Candida albicans
Zhang, F.-Y., Lian, N., & Li, M. (2024) · Pathogens and Disease · doi:10.1093/femspd/ftae003 · Cited by 11
Lipid-laden macrophages in atherosclerosis and cancer
Martínez-Campanario, M. C., Cortés, M., Han, L., Brischetto, A., Rivero-Soriano, P., Font-Díaz, J., Maurel, J., Andrés, V., & Postigo, A. A. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.09.007 · Cited by 9
Han, W., Zhang, D., Zhang, P., Tao, Q., Du, X., Yu, C., Dong, P., & Zhu, Y. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04253-9 · Cited by 7
van Wouw, S. A. E., Loix, M., Ottenhoff, R., Kingma, J., Jongejan, A., Bogie, J. F. J., Hoekstra, M., & Zelcer, N. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.119163 · Cited by 9
Martens, N., Zhan, N., Yam, S. C., Palumbo, M., Pontini, L., Leijten, F. P. J., der Zee, L. V. V., Voortman, G. J., Friedrichs, S., Gerding, A., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70031 · Cited by 7
Fan, J., Zhu, T., Tian, X., Wang, M., Li, Z., & Li, W. (2025) · Phytotherapy Research · doi:10.1002/ptr.70027 · Cited by 9
Liu, D., Ye, Y., Lan, Z., Chen, A., Zhou, X., Li, Z., Wen, X., Xiao, J., Ouyang, F., & Yan, J. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103961 · Cited by 7
The interplay between NLRP3 inflammasome and metabolic signals in gouty arthritis
Cao, D., Pu, H.-Y., Yuan, X., Li, Z., Yu, X., & Shi, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1761121 · Cited by 8
Zhang, J., You, X., Kang, D., & Zhou, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.932786 · Cited by 6
Zebrafish pten Genes Play Relevant but Distinct Roles in Antiviral Immunity
Pereiro, P., Figueras, A. J., & Novoa, B. (2020) · Vaccines · doi:10.3390/vaccines8020199 · Cited by 7
Soehnlein, O., Bazioti, V., & Westerterp, M. (2018) · Circulation Research · doi:10.1161/circresaha.118.313110 · Cited by 7
Self-citationAggressive cholesterol lowering normalizes atherosclerosis regression in Jak2V617F mice
Hardaway, B. D., Fidler, T. P., Tavallaie, M. S., Hsu, C.-C., Schiavone, S., Xiao, T., Wang, R., Wang, N., & Tall, A. R. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101003 · Cited by 6
Self-citationLateef, S. S., Ward, G., Li, H., Pantoja, C. J., Florida, E. M., Hong, C. G., Rodante, J. A., Keel, A., Chen, M. Y., Sorokin, A. V., et al. (2023) · JID Innovations · doi:10.1016/j.xjidi.2023.100243 · Cited by 6
Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges
Liu, W., Mossel, P., Schwach, V., Slart, R. H. J. A., & Luurtsema, G. (2023) · Pharmaceuticals · doi:10.3390/ph16121715 · Cited by 6
Cell membrane biomimetic magnetic fluorescent bifunctional nanoplatform for drug lead discovery
Wang, R., Qin, Y., Jiang, X., Bai, H., Liu, Y., Gao, X., & Zhao, L. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.343583 · Cited by 6
IRE1α: from the function to the potential therapeutic target in atherosclerosis
Zhou, Z., Wu, L., Liu, Y., Tang, M.-Y., Tang, J., Deng, Y.-Q., Liu, L., Nie, B.-B., Zou, Z.-K., & Huang, L. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04780-6 · Cited by 6
Wang, T., Liu, X., Zhu, Y., Zhang, Y., Zhang, Z., Huang, G. H., & Xu, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1325488 · Cited by 6
Cholesterol-dependent inflammasome activation accelerates atherosclerosis
Bras, A. L. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0012-1 · Cited by 6
MicroRNA-9-3p inhibits endothelial pyroptosis in atherosclerosis by targeting the PTEN/AKT axis
Wu, Y., Ma, Q., Meng, X., Sun, Q., Wang, Z., & Zhang, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144289 · Cited by 5
Zhang, M., Gao, S., Tan, N., Yan, Y., Zhu, R., Liu, J., Mao, Q., Wang, K., Zhang, W., Wang, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103802 · Cited by 6
Anti-inflammatory strategies for patients with atherosclerotic coronary disease
Imbesi, A., Greco, A., & Capodanno, D. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2564137 · Cited by 5
Demandt, J. A. F., van Kuijk, K., Theelen, T. L., Marsch, E., Heffron, S. P., Fisher, E. A. A., Carmeliet, P., Biessen, E. A. L., & Sluimer, J. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.664258 · Cited by 7
Karasawa, T., Komada, T., Baatarjav, C., Aizawa, E., Mizushina, Y., Fujimura, K., Gunji, Y., Komori, S., Aizawa, H., Tao, C. B. J., et al. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149158 · Cited by 5
Liang, L., Chung, S. I., Guon, T., Park, K. H., Lee, J., & Park, J. (2024) · Respiratory Research · doi:10.1186/s12931-024-02842-x · Cited by 5
Lee, M.-F., Wang, N. M., Chu, Y.-W., Wu, C., & Lin, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011278 · Cited by 5
Self-citationGhaffari, T., Moradi, N., Chamani, E., Ebadi, Z., Fadaei, R., Alizadeh‐Fanalou, S., Yarahmadi, S., & Fallah, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220401143249 · Cited by 5
Liu, G., Hu, X., Li, Y., & Long, M. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24716 · Cited by 5
Berg, A., Petrole, R. F., Li, H., Sorokin, A. V., González‐Cantero, Á., Playford, M. P., Mehta, N. N., & Teague, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1041457 · Cited by 5
Engineered immune-driven theranostics for clinical cardiology
Zheng, J.-B., Li, X., Zhu, J., Liu, C., Song, X., Wang, B., Deng, Y. W., Feng, Y.-X., Wang, Q., Liu, J., et al. (2025) · Military Medical Research · doi:10.1186/s40779-025-00664-6 · Cited by 4
Liu, M., Mo, D.-G., Bai, J., Han, Q.-F., & Yao, H.-C. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm42822 · Cited by 5
Interleukin-18 Inhibition Aggravates Atherosclerosis in Jak2 Clonal Hematopoiesis
Tavallaie, M. S., Hsu, C.-C., Hardaway, B. D., Dou, H., Fidler, T. P., Kim, E., Schiavone, S., Ngai, D., Xiao, T., Wang, N., et al. (2026) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2025.101463 · Cited by 4
Self-citationMu, W.-J., Wei, S.-Q., Peng, W.-Q., & Guo, L. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103141 · Cited by 4
Ziaee, S. M., Nemati, S. H., Kataria, H., Jakova, E., Hosseini, S. M., Ghelich, P., McLeod, G. A., Tamayol, A., Yong, V. W., & Karimi‐Abdolrezaee, S. (2026) · Nature Communications · doi:10.1038/s41467-026-72639-7 · Cited by 4
HDL Are Host Defense Lipoproteins
von Eckardstein, A., & Robert, J. (2026) · Circulation Research · doi:10.1161/circresaha.126.327426 · Cited by 5
A novel dammarane triterpenoid alleviates atherosclerosis by activating the LXRα pathway
Huang, Y. H., Ran, X., Liu, H., Luo, M., Qin, Y., Yan, J., Li, X., & Jia, Y. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00758-0 · Cited by 4
Huang, Y., Feng, J., Li, Q., Zhang, Z., Jiang, B., Amoah, K., Huang, Y., & Jian, J. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108925 · Cited by 4
Viana, G. D. A., da Costa, M. D. R., da Silva, M. E., Duque, B. R., de Siqueira, E. A., Martins, A. M. C., Alves, R. D. S., de Menezes, R. R. P. P. B., de Queiroz, M. G. R., & Sampaio, T. L. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110645 · Cited by 4
Zhang, S., Yang, F., Shi, R., Liu, C., Zhao, L., Gu, X., Liu, Y., Fu, F., Feng, N., Liu, Y., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155659 · Cited by 4
Myeloid Cell Diversity and Impact of Metabolic Cues during Atherosclerosis
Gallerand, A., Stunault, M. I., Merlin, J., Guinamard, R., Yvan‐Charvet, L., & Ivanov, S. (2020) · Immunometabolism · doi:10.20900/immunometab20200028 · Cited by 6
Hippo pathway and NLRP3-driven NETosis in macrophages: Mechanisms of viral pneumoniaaggravation
Luo, B., Wang, X., Lin, J., Mo, J., Xie, J., Zhou, Y., Feng, J., & Pan, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02556-z · Cited by 3
Boucher, D. M., Lorant, V., Rochon, V., Carter, A., Stotts, C., Nguyen, M.-A., Laval, T., Emerton, C., Joyce, N., Vinayak, N., et al. (2026) · Advanced Science · doi:10.1002/advs.202511121 · Cited by 3
Self-citationRoule, V., Beygui, F., Guérin, M., Materne, C., Procopi, N., Rahoual, G., Guedeney, P., Zeitouni, M., Kernéis, M., Montalescot, G., et al. (2025) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuaf070 · Cited by 3
Moon, H.-R., & Yun, J. (2025) · Food & Nutrition Research · doi:10.29219/fnr.v69.10763 · Cited by 3
[Gout in the area of the cervical vertebrae and the sternoclavicular joint].
Kern, A., Schunk, K., & THELEN, M. (1999) · PubMed · Cited by 3
A New Small Molecule Increases Cholesterol Efflux
Groenen, A. G., & Westerterp, M. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.315930 · Cited by 3
Self-citationChen, C., Liu, Q., Li, Y., Yu, J., Wang, S.-D., Xu, J.-L., & Liu, L. (2024) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2024.2340751 · Cited by 2
Cai, L., Lin, Z., Zhao, J., & Zhou, S. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf163 · Cited by 2
HDL in Abdominal Aortic Aneurysm: Mechanistic Insight and Therapeutic Potential
Catalano, J. C., Guo, Y., Bordeau, B. M., Yu, M., & Schwendeman, A. A. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01378-9 · Cited by 2
Possenriede, L., Sendtner, G. W., Falahat, P., Scheidt, U., Miranda, J., Schmitz, J., Bräsen, J. H., & von Vietinghoff, S. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00914.2025 · Cited by 2
LL-37–ApoB-100 Complex Serves as a Biomarker of Coronary Artery Disease
Fang, Y., Zhang, Z., Cao, Q., Li, Y., Duan, Y., 邦猛, 平., Duan, Z., Gan, W., Gao, J., Hua, M., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323486 · Cited by 2
Self-citationDu, L., Wang, Y., Ma, H., Fan, J., Wang, S., Liu, J., & Wang, X. (2024) · Medicine · doi:10.1097/md.0000000000040773 · Cited by 2
Cross-Talk of Atherosclerosis and Ischemic Stroke: Dramatic Role of Neutrophils
Esmaeilzadeh, A., Zarerafie, M., & Mohammadzadeh, A. (2021) · Archives of Neuroscience · doi:10.5812/ans.104433 · Cited by 2
Blanchard, V., & Francis, G. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824048-9.00017-1 · Cited by 2
Dhawan, U. K., Vartak, T., Englert, H., Singhal, A., Chakraborty, R., Bhagat, K. K., Vasconcellos, L. R. C., McDonnell, C., Connolly, M., Mulkern, E., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.30.635503 · Cited by 2
Circulating cfdna: A novel biomarker for preventing early recurrence in ischemic stroke
Li, X., Yuan, Y., Jing, W., Liu, C., Wei, M., Liu, Q., Li, X., Wei, L., Du, X., & Wang, J. (2025) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-025-03179-y · Cited by 1
Fu, C., Chen, J., Liu, K., Dong, H., & Li, X. (2026) · Mediators of Inflammation · doi:10.1155/mi/1925004 · Cited by 1
Sirtl, S., Ahmad, M., Allawadhi, P., Metzler, T., Buchstab, O., Ormanns, S., Rudelius, M., Beyer, G., Krupa, Ł., Staron, R., et al. (2026) · United European Gastroenterology Journal · doi:10.1002/ueg2.70198 · Cited by 1
GPR30-mediated NETs degradation via Trex1 in heart failure of aged female mice
Zhang, S., Li, Z., Wang, X., Wang, X., Du, J., Liu, J., Cheng, Z., Zhao, D., 段维勋, Ma, J., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08088-z · Cited by 1
Yuan, Y., Shou, K.-Y., Wu, S., Zhao, J., Liu, Y., Wang, Y., Luo, H.-S., & Dai, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1793697 · Cited by 1
Liang, Y., Jiang, X., Liu, J., Lu, F., Chen, P., & Liu, S. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116817 · Cited by 1
Wang, Z., Qu, Y., Wang, H., & Liu, X. (2026) · Clinical Interventions in Aging · doi:10.2147/cia.s608687 · Cited by 1
Buzetti, L. C., Prado, L. C., Silva, V. F., Moretti, V. B., de Lima, J. A., Batista, S. O., & de Carvalho, A. M. (2024) · Brazilian Journal of Development · doi:10.34117/bjdv10n8-024 · Cited by 1
Tang, Y., Tong, W., Peng, Y., & Sun, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10554-8 · Cited by 3
Colchicine as a Potential Anti-Inflammatory Strategy for Aortic Aneurysm
Karasawa, T., & Takahashi, M. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0703 · Cited by 1
High-density lipoprotein lifts the “dark web” cast by neutrophils
Lucero, D., Neufeld, E. B., & Remaley, A. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.09.28 · Cited by 1
Enhancing Atherosclerosis Regression in Diabetic Mice Through Apo AI (Apolipoprotein AI)
Rader, D. J. (2019) · Circulation · doi:10.1161/circulationaha.119.040369 · Cited by 1
Blocking Interleukin-1β: A Double-Edged Sword in Experimental Atherosclerosis
MacRitchie, N. A., & Maffia, P. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.124.321113 · Cited by 1
Fais, R. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2020.tde-05062020-084655
Li, J., Liu, J., Yu, Y., Liu, Y., & Guan, X. (2021) · Research Square · doi:10.21203/rs.3.rs-773064/v1
Li, J., Liu, J., Yu, Y., Liu, Y., & Guan, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1243783/v1
Regulation of neutrophil NETosis by inflammasome
Hogg, A. J., Barlow, J. L., & Boucher, D. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00036-0
Metadata
- Authors
- Westerterp, M., Fotakis, P., Ouimet, M., Bochem, A. E., Zhang, H., Molusky, M. M., Wang, W., Abramowicz, S., la Bastide-van Gemert, S., Wang, N., Welch, C. L., Reilly, M. P., Stroes, E. S., Moore, K. J., & Tall, A. R.
- Affiliations
- Division of Molecular Medicine (M.W., P.F., A.E.B., M.M.M., W.W., S.A., N.W., C.L.W., A.R.T.)
- University of Ottawa (CA)
- Amsterdam UMC Location University of Amsterdam (NL)
- Columbia University Irving Medical Center (US)
- Department of Epidemiology (S.l.B-v.G.), University of Groningen, University Medical Center Groningen, The Netherlands
- NYU Langone Health (US)
- Corresponding author
- Westerterp, Marit
- Fotakis, Panagiotis
- ORCID
- Venue
- Circulation
- Published
- 2018-08-28
- Volume
- 138
- Issue
- 9
- Pages
- 898-912
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC6160368
- OpenAlex
- W2795137969
- Cited by
- 331
- References
- 49
- Citations by year
- 2026: 37 · 2025: 40 · 2024: 41 · 2023: 47 · 2022: 45 · 2021: 45 · 2020: 36 · 2019: 28 · 2018: 11
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
- Funders
- University of Ottawa
- York University
- Rijksuniversiteit Groningen
- Universiteit van Amsterdam
- Universitair Medisch Centrum Groningen
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K24HL107643, R01HL113147, R01HL117334, R35HL135799, K99HL130574, R01HL107653, T32HL007343)
- National Center for Research Resources (S10RR027050)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- cholesterol efflux, ABCA1, ABCG1, NLRP3 inflammasome, caspase-1, caspase-11, IL-1β, IL-18, NETosis, atherogenesis, myeloid cells, non-canonical inflammasome, Tangier disease
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 1, NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cholesterol, Disease Models, Animal, Humans, Inflammation, Receptors, LDL, Spleen, Tangier Disease, Case-Control Studies, Cytokines, Mice, Knockout, Caspases, Caspase 1, Myeloid Cells, Atherosclerosis, Caspases, Initiator, Plaque, Atherosclerotic, Inflammasomes, ATP Binding Cassette Transporter 1, Extracellular Traps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review